CuppsR. E., UtzD. C., FlemingT. R., CarsonC. C., ZinckeH., MeyersR. P.: Definitive radiation therapy for prostatic carcinoma: Mayo clinic experience. J. Urol., 124; 855–858 (1980).
2.
EdsmyrF., EspostiP. L., AndrerssonL.: Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate. Scand. J. Urol. & Nephrol., 14; 139–142 (1980).
3.
EspostiP. L.: Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand. J. Urol. & Nephrol., 5; 199–209 (1971).
4.
FaulP.: Diagnostische Möglichkeiten der Prostatazytologie unter besonderer Berücksichtigung des Einflusses des zytologischen Differenzierungsgrades beim Prostatakarzinom auf die 5 Jahres-Überlebenszeit. Arch. Geschwulstforsch., 49; 18–28 (1979).
5.
JonssonG., HogbergB.: Treatment of advanced prostatic carcinoma with Estracyt. Scand. J. Urol. & Nephrol., 5; 103–107 (1971).
6.
KieslingV. J., McAninchJ. W., GoebelJ. L., AgeeR. E.: External beam radiotherapy for adenocarcinoma of the prostate: a clinic follow up. J. Urol., 124; 851–853 (1980).
7.
LeistenechneiderW., NagelR.: Cytological and DNA-cytophotometric monitoring of the effect of therapy in conservatively treated prostatic carcinoma. Scand. J. Urol. & Nephrol., 14; 197–204 (1980).
8.
StaehlerW., ZieglerH.: Compendio atlante di citodiagnostica prostatica.Edizioni C.E.L.I., Bologna1976.
